B
Bushra Ijaz
Researcher at University of the Punjab
Publications - 64
Citations - 1165
Bushra Ijaz is an academic researcher from University of the Punjab. The author has contributed to research in topics: Hepatitis C virus & Medicine. The author has an hindex of 18, co-authored 50 publications receiving 885 citations.
Papers
More filters
Journal ArticleDOI
Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation
TL;DR: The mechanisms involved in ROS production and their possible association with AD and T2DM pathogenesis and progression are summarized and the role of current treatments that can be linked with reduced oxidative stress and damage is highlighted.
Journal ArticleDOI
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
Waqar Ahmad,Bushra Ijaz,Fouzia T Javed,Sana Gull,Humaira Kausar,Muhammad Sarwar,Sultan Asad,Imran Shahid,Aleena Sumrin,Saba Khaliq,Shah Jahan,Asim Pervaiz,Sajida Hassan +12 more
TL;DR: The fibrosis-cirrhosis index (FCI) accurately predicted fibrosis stages in HCV infected patients and seems more efficient than frequently used serum indexes.
Journal ArticleDOI
HCV genotype distribution and possible transmission risks in Lahore, Pakistan
Waqar Ahmad,Bushra Ijaz,Fouzia T Javed,Shah Jahan,Imran Shahid,Fawad Mumtaz Khan,Sajida Hassan +6 more
TL;DR: An increase in genotypes 1a and 4a suggest migration of people, possibly from Balochistan and the northern war-zone area, and government should focus on public education regarding infection routes.
Journal ArticleDOI
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation
Waqar Ahmad,Bushra Ijaz,Sana Gull,Sultan Asad,Saba Khaliq,Shah Jahan,Muhammad Sarwar,Humera Kausar,Aleena Sumrin,Imran Shahid,Sajida Hassan +10 more
TL;DR: Non-invasive serum markers for HCV, FibroTest, Forn's Index, Fibrometer and HepaScore have high five-year predictive value but are not comparable to liver biopsy and genetic marker in combination of imaging technique may be the better non invasive diagnostic method in future.
Journal ArticleDOI
RNAi as a new therapeutic strategy against HCV.
Saba Khaliq,Sadaf A. Khaliq,Muzna Zahur,Bushra Ijaz,Shah Jahan,Muhammad Ansar,Sheikh Riazuddin,Sajida Hassan +7 more
TL;DR: The present review focused on the recent development in the potential use and issues regarding siRNA as a therapy for HCV.